Shopping Cart
- Remove All
- Your shopping cart is currently empty
SR-2890 is a potent and highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitor with an IC50 of 4 nM for CK1δ. This compound inhibits melanoma A375 cell growth with an EC50 of 38 nM in MTT assays and possesses pharmacokinetic properties suitable for xenograft studies using human cancer cell lines.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $195 | In Stock | |
5 mg | $483 | In Stock | |
10 mg | $691 | In Stock | |
25 mg | $1,080 | In Stock | |
50 mg | $1,490 | In Stock |
Description | SR-2890 is a potent and highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitor with an IC50 of 4 nM for CK1δ. This compound inhibits melanoma A375 cell growth with an EC50 of 38 nM in MTT assays and possesses pharmacokinetic properties suitable for xenograft studies using human cancer cell lines. |
In vivo | SR-2890 (1 mg/kg, intravenous administration) was used to treat mice bearing human brain tumor xenograft models to investigate its pharmacodynamics and pharmacokinetics. Results: SR-2890 had a half-life of 1.5 hours in mice and was suitable for xenograft studies of human cancers. [1] |
Synonyms | SR2890 |
Molecular Weight | 477.93 |
Formula | C23H21ClFN9 |
Cas No. | 1454584-91-8 |
Smiles | FC1=CC=CC(=C1)N2C=NC=3C(=NC(=NC32)N4CCNCC4)NCC5=NC=6C=CC(Cl)=CC6N5 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.